Join
Live feed
·
PRReleasevia Quantisnow
Silo Pharma Inc. logo

Silo Pharma Adds Japanese Patent to Expanding Global IP Portfolio for Licensed PTSD Drug

ByQuantisnow·Wall Street's wire, on your screen.
SILO· Silo Pharma Inc.
Consumer Discretionary

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SILO (Silo Pharma Inc.) and more on Quantisnow.